Hinge Health: James Budge proposes $4.91M share sale

The prior-three-months table lists a September 10, 2026 sale of 55,561 shares, with an aggregate market value of $4,969,997.03.

Rhea-AI Filing Summary

Hinge Health, Inc. (HNGE) lists 47,720 common shares to be sold by Officer James Budge, with an aggregate market value of $4,910,388.00 through Morgan Stanley Smith Barney LLC. The listed approximate sale date is October 12, 2026. The securities were acquired upon vesting of restricted stock units from May 21, 2025 through October 10, 2026. The past-three-month sales section lists 55,561 common shares sold on September 10, 2026, with an aggregate market value of $4,969,997.03, and labels those sales as 10b5-1 sales for James Budge.

Key Figures

Common shares listed for sale: 47,720 shares Aggregate market value: $4,910,388.00 Common shares sold: 55,561 shares +1 more

4 metrics

Common shares listed for sale 47,720 shares Approximate sale date: October 12, 2026

Aggregate market value $4,910,388.00 Shares listed for sale

Common shares sold 55,561 shares September 10, 2026; past-three-month sales section

Aggregate market value $4,969,997.03 September 10, 2026 sale

Key Terms

10b5-1 Sales, Restricted Stock Units, Rule 144

3 terms

10b5-1 Sales regulatory

"10b5-1 Sales for JAMES BUDGE"

10b5-1 sales are pre-arranged stock-trading plans that let company insiders automatically buy or sell shares according to a fixed schedule or formula, even if they later learn confidential information. Think of it as setting up an automatic thermostat for trades: it creates a clear, documented path that can protect insiders from insider-trading accusations and gives investors a signal about predictable insider activity—though it can also simply be a way for insiders to diversify or raise cash.

Restricted Stock Units financial

"acquired upon the vesting of restricted stock units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Rule 144 regulatory

"paragraph (a) of Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many HNGE shares did James Budge report for sale?

The notice lists 47,720 common shares for sale, with an aggregate market value of $4,910,388.00; it gives October 12, 2026 as the approximate sale date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/13/2026 - 08:20 AM EDT Accepted by SEC EDGAR 10/13/2026 - 08:20 AM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001338176
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Hinge Health, Inc.
SEC File Number	001-42657
Address of Issuer	455 Market Street, Suite 700 San Francisco CALIFORNIA 94105
Phone	4157262206
Name of Person for Whose Account the Securities are To Be Sold	JAMES BUDGE
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	47720	4910388.00	62468721	10/12/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/21/2025	Restricted Stock Units	Issuer			47720	05/21/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for JAMES BUDGE 455 Market Street, Suite 700 San Francisco CA 94105	Common	09/10/2026	55561	4969997.03

144: Remarks and Signature

Remarks	The securities to be sold were acquired upon the vesting of restricted stock units during the period of 05/21/2025 through 10/10/2026. Sales that were executed on October 12, 2026 are being reported on this Form 144 filed on October 13, 2026 given the EDGAR system was not accepting filings on October 12, 2026 in observance of the federal holiday.
Date of Notice	10/12/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/11/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ James Budge
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)